Suppression of Nitric Oxide Synthase by Thienodolin in Lipopolysaccharide-stimulated RAW 264.7 Murine Macrophage Cells

Park, EJ; Pezzuto, JM; Jang, KH; Nam, SJ; Bucarey, SA; Fenical, W

Keywords: inflammation, nitric oxide, macrophage, inducible nitric oxide synthase, cancer prevention, Thienodolin

Abstract

The measurement of nitric oxide in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells is used as a model for evaluating the anti-inflammatory or chemopreventive potential of substances. Thienodolin, isolated from a Streptomyces sp. derived from Chilean marine sediment, inhibited nitric oxide production in LPS-stimulated RAW 264.7 cells (IC50 = 17.2 +/- 1.2 mu M). At both the mRNA and protein levels, inducible nitric oxide synthase (iNOS) was suppressed in a dose-dependent manner. Mitogen-activated protein kinases (MAPKs), one major upstream signaling pathway involved in the transcription of iNOS, were not affected by treatment of thienodolin. However, the compound blocked the degradation of I kappa B alpha resulting in inhibition of NF-kappa B p65 nuclear translocation, and inhibited the phosphorylation of signal transducers and activators of transcription 1 (STAT1) at Tyr701. This study supports further exploration of thienodolin as a potential therapeutic agent with a unique mechanistic activity.

Más información

Título según WOS: Suppression of Nitric Oxide Synthase by Thienodolin in Lipopolysaccharide-stimulated RAW 264.7 Murine Macrophage Cells
Título de la Revista: NATURAL PRODUCT COMMUNICATIONS
Volumen: 7
Número: 6
Editorial: SAGE PUBLICATIONS INC
Fecha de publicación: 2012
Página de inicio: 789
Página final: 794
Idioma: English
Notas: ISI